Ju-Hsien "John" Chao, D.O.

Phuong Ngo, M.D.

Ju-Hsien "John" Chao, D.O.

  • Assistant Professor of Medicine
UofL Health - Brown Cancer Center
529 South Jackson Street
Louisville, KY 40202

502-852-2522 - Academic Office
502-562-4370 - Patient Appointments


Clinical Expertise
Hematology; Blood and Bone Marrow Transplantation


Board Certifications

  • American Board of Internal Medicine -
    Medical Oncology / Hematology

Education and Training

  • Medical School: Texas College of Osteopathic Medicine
  • Residency: University of North Texas Health Science Center
  • Fellowship: University of Louisville

Get To Know Dr. Chao


Featured Publications

  • Castillo BS, Rodriguez ML, John Chao JH, Zoghi B. Primary Cutaneous Diffuse Large B-Cell Lymphoma of the Upper Limb: Double Hit/Double Expressor with CNS Involvement: From Hospice to Remission. Case Rep Hematol. 2019 Feb 7;2019:3953470. doi: 10.1155/2019/3953470. PMID: 30881709; PMCID: PMC6383425.
  • Gosain R, Gill A, Fuqua J, Volz LH, Kessans Knable MR, Bycroft R, Seger S, Gosain R, Rios JA, Chao JH. Gemcitabine and carfilzomib induced thrombotic microangiopathy: eculizumab as a life-saving treatment. Clin Case Rep. 2017 Oct 9;5(12):1926-1930. doi: 10.1002/ccr3.1214. PMID: 29225827; PMCID: PMC5715608.
  • Diaz JA, Rai SN, Wu X, Chao JH, Dias AL, Kloecker GH. Phase II Trial on Extending the Maintenance Flushing Interval of Implanted Ports. J Oncol Pract. 2017 Jan;13(1):e22-e28. doi: 10.1200/JOP.2016.010843. Epub 2016 Oct 23. PMID: 28084883.
  • Park J, Kim S, Joh J, Remick SC, Miller DM, Yan J, Kanaan Z, Chao JH, Krem MM, Basu SK, Hagiwara S, Kenner L, Moriggl R, Bunting KD, Tse W. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling. Oncotarget. 2016 Jul 12;7(28):43960-43973. doi: 10.18632/oncotarget.9759. PMID: 27259262; PMCID: PMC5190071.
  • Toro JJ, Haile DJ, Chao JH, Schneider D, Jewell PS, Lee S, Freytes CO. The department of veterans affairs nutritional status classification scheme allows for rapid assessment of nutritional status prior to autologous peripheral blood stem cell transplantation and identifies patients at high risk of transplant-related complications. Biol Blood Marrow Transplant. 2009 Sep;15(9):1060-5. doi: 10.1016/j.bbmt.2009.05.004. Epub 2009 Jun 26. PMID: 19660718.